HomeStock ScreenerLotus Eye Hospital

Lotus Eye Hospital Share Price | Lotus Eye Hospital Stock Screener

LOTUSEYE Hospitals
Share Price NSE
₹119.06
▲ 0.70 (0.59%)
2026-07-24 00:00:00
Share Price BSE
₹120.05
▲ 0.60 (0.50%)
2026-07-24 00:00:00
As of July 24, 2026, the Lotus Eye Hospital share price (NSE: LOTUSEYE) is ₹119.06 on NSE and ₹120.05 on BSE, up 0.59% from the previous close, with shares trading between ₹117.01 and ₹121.98, and a 52-week range of ₹72.10–₹141.38. Analyse Lotus Eye Hospital share price performance and track historical price performance. Use the Lotus Eye Hospital stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Lotus Eye Hospital Market Cap ₹253.24 Cr.
LOTUSEYE P/E Ratio (TTM) 3045.00
Lotus Eye Hospital P/B Ratio 4.21
EPS (TTM) ₹0.36
Dividend Yield -
Debt to Equity 0.04
LOTUSEYE 52 Week High ₹141.38
Lotus Eye Hospital 52 Week Low ₹72.10
Operating Margin 7.00%
Profit Margin 1.96%
LOTUSEYE Revenue (TTM) ₹51.00
EBITDA ₹5.00
Net Income ₹1.00
Total Assets ₹83.00
Total Equity ₹60.00

Lotus Eye Hospital Share Price Chart

Screen Lotus Eye Hospital share price with an interactive chart. Analyse LOTUSEYE price trends and volatility across different timeframes.

Lotus Eye Hospital Company Profile - Fundamental Screener

Screen Lotus Eye Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LOTUSEYE shares.
Sector Healthcare Services
Industry Hospitals
Sub-Sector Hospitals
Segment E
ISIN INE947I01017

Lotus Eye Hospital Balance Sheet Screener

Screen LOTUSEYE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 83 70 67 63 62 59 58 57 58 55
Current Assets 11 12 14 15 13 14 11 7 8 7
Fixed Assets 66 54 49 44 44 41 43 44 43 41
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 13 2 1 0 1 1 1 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 60 60 59 58 55 53 51 50 51 50
Share Capital 21 21 21 21 21 21 21 21 21 21
Reserves & Surplus 39 39 39 37 34 32 31 29 30 29

Lotus Eye Hospital Income Statement Screener - Profit & Revenue Analysis

Screen Lotus Eye Hospital income statement and profit fundamentals. Analyze LOTUSEYE quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Lotus Eye Hospital share price evaluation.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 51 50 48 40 33 42 39 39 35 32 30
Expenses 46 42 40 33 29 37 35 34 31 27 28
EBITDA 5 8 9 7 4 5 4 5 4 5 3
Operating Profit % 7.00% 14.00% 16.00% 15.00% 11.00% 9.00% 8.00% 11.00% 10.00% 13.00% 7.00%
Depreciation 3 4 3 3 2 3 3 3 3 4 5
Interest 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 4 6 4 2 2 1 2 0 0 -2
Tax 1 1 2 1 0 0 0 0 0 0 0
Net Profit 1 3 4 3 2 1 1 2 0 0 -2
EPS 0.36 1.40 1.96 1.44 0.75 0.51 0.34 0.84 0.21 0.05 -0.95

Lotus Eye Hospital Cash Flow Screener - Liquidity Fundamentals

Screen LOTUSEYE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 3 6 4 4 3 5 4 6 3 3
Investing Activities -6 -5 -2 -4 1 -1 -4 -4 -1 -1
Financing Activities -2 -3 -2 -2 0 0 -1 -2 0 -1
Net Cash Flow -5 -2 1 -1 3 4 -1 0 2 2

Lotus Eye Hospital Shareholding Pattern Screener

See Lotus Eye Hospital shareholding pattern with promoter, FII, and DII holdings. Check Lotus Eye Hospital promoter holding and ownership changes for LOTUSEYE on TickJournal.
Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept
Promoter Holding 40.14% 40.14% 40.67% 40.64% 40.39% 40.22% 40.14% 40.03%
FII Holding 0.00% 0.00% 0.01% 0.00% 0.01% 0.00% 0.00% 0.00%
DII Holding 0.02% 0.02% 0.02% 0.02% 0.02% 0.04% 0.04% 0.03%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 36.43% 36.73% 38.12% 38.70% 39.03% 40.95% 41.73% 42.84%
Other Holding 23.41% 23.11% 21.18% 20.64% 20.55% 18.79% 18.09% 17.10%
Shareholder Count 9,627 9,939 10,240 10,777 11,121 11,508 11,734 12,514

Lotus Eye Hospital Share Dividend Screener - Share Yield Analysis

Check Lotus Eye Hospital dividend history with payout and yield data. View Lotus Eye Hospital dividend details including ex-dates and amounts for LOTUSEYE stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.50 0.87%
2021-March ₹0.50 0.94%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.50 2.27%
2017-March ₹0.50 1.81%

Lotus Eye Hospital Stock Index Membership

See which indices include Lotus Eye Hospital stock. Check LOTUSEYE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Lotus Eye Hospital is not part of any tracked indices.
Only major market indices are tracked in our system.

Lotus Eye Hospital Market Events Screener - Corporate Actions

Get Lotus Eye Hospital corporate actions including splits, bonuses, and buybacks. Check Lotus Eye Hospital stock events that may affect LOTUSEYE share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-26 2026-05-26 Quarterly Result Announcement NA -0.86%
2026-02-11 2026-02-11 Quarterly Result Announcement NA -14.00%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -2.78%
2025-09-23 2025-09-23 Annual General Meeting NA 12.18%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 0.12%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -1.55%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 2.12%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -8.46%
2024-08-13 2024-08-13 Annual General Meeting NA 5.50%
2023-09-18 2023-09-18 Dividend ₹ 0.50 /share 11.71%
2022-09-08 2022-09-10 Dividend ₹ 0.50 /share 37.48%
2021-09-08 2021-09-11 Dividend ₹ 0.50 /share -10.42%
2017-06-06 2017-06-06 Change Of Name NA -

Lotus Eye Hospital Competitors Screener - Peer Comparison

Screen LOTUSEYE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 127,875 63.97 25,229 14.70% 2,032 63.79
Max Healthcare Institute 107,057 74.35 8,536 18.82% 1,442 54.06
Fortis Healthcare 72,397 67.51 9,179 16.93% 1,064 45.61
Aster DM Healthcare 42,735 166.24 4,643 8.32% 384 59.18
Narayana Hrudayalaya 41,422 51.37 7,896 41.63% 788 59.75
Global Health 36,308 64.62 4,410 16.94% 584 57.66
Krishna Institute of Medical Sciences 33,164 136.90 3,905 27.31% 198 45.89
Dr. Agarwal's Health Care 15,497 91.34 2,080 18.39% 168 55.17
Rainbow Childrens Medicare 15,081 53.78 1,747 11.49% 282 66.18
Park Medi World 11,995 44.08 1,679 17.77% 272 48.31

Lotus Eye Hospital Company Announcements - News Screener

Screen LOTUSEYE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-07-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-05-28 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-26 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-26 Board Meeting Outcome for Outcome Of The Board Meeting -
2026-05-26 Standalone Audited Financial Results For Quarter And Year Ended March 31 2026 -
2026-05-21 Board Meeting Intimation for Standalone Audited Financial Results For The Quarter And Year Ended March 31 2026 -
2026-05-08 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-04-18 Non-Applicability Of SEBI Circular On Large Corporates -
2026-04-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-26 Closure of Trading Window -
2026-03-17 Board Meeting Outcome for Outcome Of The Board Meeting -
2026-03-12 Board Meeting Intimation for To Consider The Proposal For Voluntary Delisting Of The Companys Equity Shares From NSE. -
2026-03-04 Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order -
2026-03-02 Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 -
2026-02-12 Board Comments On Imposition Of Fine Under Regulation 17(1A) Of SEBI (LODR) 2015 -
2026-02-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-12 Appointment of Company Secretary and Compliance Officer -
2026-02-11 Outcome Of The Board Meeting -